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ABSTRACT  
 
Background:  
Recent evidence suggests that combining individual imaging markers of cerebral small vessel 
disease (SVD) may more accurately reflect its overall burden and better correlate with clinical 
measures.  
 
Objective: 
We established the clinical relevance of the total SVD score in a memory clinic population by 
investigating the association with SVD score and cognitive performance, cortical atrophy and 
structural network measures, after adjusting for amyloid-β. 
 
 
Methods:  
We included 243 patients with amnestic mild cognitive impairment (MCI), Alzheimer’s disease 
dementia, subcortical vascular MCI, or subcortical vascular dementia. All underwent MR and [11C] 
PiB PET scanning, and had standardized cognitive testing. Multiple linear regression was used to 
evaluate the relationships between SVD score and cognition, cortical thickness and structural 
network measures. Path analyses were performed to evaluate whether network disruption mediates 
the effects of SVD score on cortical thickness and cognition.  
 
Results:  
Total SVD score was associated with the performance of frontal (β -4.31, SE 2.09, p = 0.040) and 
visuospatial (β -0.95, SE 0.44, p = 0.032) tasks, and with reduced cortical thickness in widespread 
brain regions. Total SVD score was negatively correlated with nodal efficiency, as well as changes 
in brain network organization, with evidence of reduced integration and increasing segregation. 
Path analyses showed that the associations between SVD score and frontal and visuospatial scores 
were partially mediated by decreases in their corresponding nodal efficiency and/or cortical 
thickness.  
 
Conclusion:  
Total SVD burden has clinical relevance in a memory clinic population and correlates with 
cognition, cortical atrophy, as well as structural network disruption.  
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INTRODUCTION     
Cerebral small vessel diseases (SVD) are common age-related pathologies that affect the brain[1]. 
There are a number of recognized structural markers of SVD, including white matter 
hyperintensities (WMH), lacunes, cerebral microbleeds and MRI-visible perivascular spaces, but 
their individual correlation with clinical measures, in particular cognition, is often inconsistent[2]. 
A recently developed “total SVD score”[3] combines these separate imaging markers in an attempt 
to more closely reflect overall burden, and has shown associations with a number of clinical 
measures including cognitive performance[4-7], recurrent stroke[8], gait and balance measures[9, 
10] and mortality[11]. However, the majority of these studies are in populations with high 
cardiovascular risk, for example those with hypertension, previous transient ischemic attacks 
(TIA) or ischemic stroke, with a few in the healthy elderly (aged over 60 years)[5, 7].  Patients 
with mild cognitive impairment or dementia differ from these patient groups because they more 
frequently have other coexistent neuropathologies together with SVD, in particular, amyloid-beta 
(Aβ) deposition. It is not known whether the SVD score has clinical relevance in this patient cohort, 
given that alternate pathologies may make the dominant contribution in these cases.  
 
One method of estimating the impact of SVD has been to use network measures, based on the 
hypothesis that these SVD processes disrupt the normal connectivity of the brain[12]. The damage 
caused by SVD extends beyond that visible on brain imaging; for example, “normal appearing” 
white matter may show diffusion tensor abnormalities in those with SVD[12, 13]. Structural 
network measures have shown correlations with the presence and progression of cognitive 
impairment[2, 14] and provide a potential mechanism by which SVD disrupts cognition. 
Individual structural markers of SVD are also associated with cortical atrophy, another imaging 
measure that correlates with cognitive dysfunction[15, 16]. The total SVD score provides a unique 
opportunity to better estimate SVD impact on both brain atrophy and structural network disruption 
in patient populations with coexisting neuropathologies. Moreover, we hypothesized that vascular 
damage in the white matter could subsequently cause structural network disruption and then 
cortical atrophy[17]; this is supported by  evidence showing that the topography of cortical atrophy 
is similar  in regions connected via damaged tracts represented by white matter 
hyperintensities[18]. Therefore, investigating whether the association between total SVD score 
and cognition is mediated by structural network disruption and cortical atrophy might help to 
emphasize the clinical relevance of total SVD score as a marker for overall SVD burden.  
 
Thus, our primary aim was to establish the clinical relevance of the total SVD score in a pooled 
memory clinic population by reviewing the cognitive associations of total SVD burden; we 
hypothesized that total SVD score would be particularly associated with “vascular” domains, in 
particular, frontal and attentional function [19], regardless of clinical diagnosis. Our second 
objective was to quantify the relative contributions of SVD (as measured by the total SVD score) 
and brain Aβ (as measured by PiB-PET) to cortical atrophy and structural brain network disruption 
(as measured by local nodal efficiency, a network parameter that quantifies the importance of each 
node for communication within a network). Finally, we explored whether any association between 
total SVD score and cognition was mediated by structural network disruption, or cortical atrophy, 
or both. In all cases, we wished to review the relative impact of pathology (and in particular small 
vessel pathology) rather than diagnosis on our measures of interest.  
 
 
 MATERIALS AND METHODS 
 
Participants 
251 subjects with cognitive impairment were prospectively recruited between July 2007 and July 
2011. All subjects were clinically diagnosed at the Samsung Medical Center, Seoul, Republic of 
Korea. In order to be included in the study, patients required a diagnosis of subcortical vascular 
mild cognitive impairment (MCI), subcortical vascular dementia, probable Alzheimer’s disease 
(AD) dementia or amnestic MCI.  
 
Subcortical vascular MCI (n=67) was defined using a previously described modification of 
Petersen’s criteria [20]. Subcortical vascular dementia (n=70) was defined clinically using the 
Diagnostic and Statistical Manual of Mental Disorder Fourth Edition and using imaging criteria 
proposed by Erkinjuntti et al[21]. Patients with subcortical MCI and subcortical vascular dementia 
all had severe white matter hyperintensities (WMH) on FLAIR, defined as periventricular WMH 
≥ 10mm and deep WMH ≥ 25mm, as modified from the Fazekas ischemia criteria[22]. 
 
Amnestic MCI (n=45) was defined by Petersen’s criteria for mild cognitive impairment (MCI). 
Probable Alzheimer’s Disease (AD) dementia (n=69) was defined using National Institute of 
Neurological and Communicative Disorders and Stroke and the AD and Related Disorders 
Association criteria[23]. Those with amnestic MCI or AD had WMH that were either minimal 
(periventricular WMH<5mm and deep WMH<5mm) or moderate (between minimal and severe 
WMH classifications).  
 Patients with territorial (i.e. large vessel) infarctions, WMH due to radiation injury, 
leukodystrophy, multiple sclerosis, or vasculitis were excluded. Whilst patients with large vessel 
infarctions were excluded, patients with a clinical history of lacunar stroke or deep intracerebral 
haemorrhage were not excluded. All patients underwent a clinical interview (for details including 
cardiovascular risk factors), neurological examination, cognitive assessment by a trained 
neuropsychologist, blood tests, APOE genotyping, PiB-PET and structural brain MRI.  
 
This study was approved by Institutional Review Board of the Samsung Medical Center. We 
obtained written consent from each patient. 
 
Neuropsychological tests 
The cognitive assessments were performed by trained neuropsychologists. Participants were tested 
using the Seoul Neuropsychological Screening Battery (SNSB), which contains tests for attention, 
language, visuospatial function, verbal and visual memory, and frontal-executive function[24, 25]. 
Attention score was calculated by summing scores in digit span forward (range 0 to 9) and digit 
span backward (range 0 to 8). Memory-domain score (memory score) was calculated by summing 
scores in verbal and visual memory tests; raw scores on Seoul Verbal Learning Test (SVLT) 
immediate recall (range 0 to 36), delayed recall (range 0 to 12), and recognition (range 0 to 24) 
and raw scores on Rey–Osterrieth Complex Figure Test (RCFT) immediate recall (range 0 to 36), 
delayed recall (range 0 to 36), and recognition (range 0 to 24) were all summated. Frontal-
executive-domain score (frontal score) was calculated by summing scores in a category word 
generation task, a phonemic word generation task, and the Stroop color-reading test (range 0 to 
120). Raw scores on Korean version of the Boston Naming Test (K-BNT) and RCFT copy test 
were used as language and visuospatial score, respectively.  
 
 
MRI acquisition   
Standardized T2-weighted, three-dimensional (3D) T1-weighted turbo field echo, 3D fluid-
attenuated inversion recovery (FLAIR), T2* gradient echo (GRE) and DTI sequences were 
acquired for all subjects at the Samsung Medical Center using the same 3.0T MRI scanner (Philips 
3.0T Achieva). We acquired 3D T1-weighted turbo field echo MR images using the following 
parameters: sagittal slice thickness of 1.0 mm, over contiguous slices with 50% overlap; no gap; 
repetition time (TR) of 9.9 msec; echo time (TE) of 4.6 msec; flip angle of 8°; and matrix size of 
240 × 240 pixels, reconstructed to 480 × 480 over a field of view (FOV) of 240 mm. The following 
parameters were used for the 3D FLAIR images: axial slice thickness of 2 mm; no gap; TR 11000 
msec; TE 125 msec; flip angle 90°; and matrix size of 512 × 512 pixels. T2* GRE images were 
obtained using the following parameters: axial slice thickness of 5.0mm, inter-slice thickness of 
2mm, TR 669 msec, TE 16 msec, flip angle 18°, and matrix size 560 × 560 pixels. In whole-brain 
DT-MRI examinations, sets of axial diffusion-weighted single-shot echo-planar images were 
collected with the following parameters: 128×128 acquisition matrix, 1.72 × 1.72 × 2 mm3 voxels; 
70 axial slices; 22 × 22 cm2 FOV; TE 60 msec, TR 7696 msec; flip angle 90°; no gap; b-factor of 
600 smm−2. Diffusion-weighted images were acquired from 45 different directions using the 
baseline image without weighting [0, 0, 0]. All axial sections were acquired parallel to the anterior 
commissure-posterior commissure line. 
 
Structural markers of cerebral small vessel disease (SVD) 
Rating was performed by trained individuals blinded to clinical details.  Two experienced 
neurologists (HJK, JHP) rated WMH severity, lacunes and cerebral microbleeds. WMH severity 
was rated using FLAIR images using the simplified Fazekas scale[22]; Interrater reliabilities for 
rating periventricular, deep, and total WMH were between 72.6 and 90.5%. Lacunes were 
identified and counted using FLAIR, T1- and T2-weighted images in accordance with STRIVE 
(STandards for ReportIng Vascular changes on nEuroimaging) criteria[26]. Cerebral microbleeds 
were rated using the validated Microbleed Anatomical Rating Scale (MARS)[27] using T2* GRE 
images. Interrater agreement was 78.0% for lacunes and 92.3% for cerebral microbleeds, and 
consensus was reached in all cases of discrepancy. MRI-visible perivascular spaces in the basal 
ganglia (BG-PVS) were defined and rated using T2-weighted images by a single rater (GB) using 
a validated four-point visual rating scale[28, 29].  
 
The SVD score was determined using a previously described four-point scale [3, 5]. This scale 
awards 1 point for the presence of each of the following (with the maximum possible score being 
4): presence of 1 or more lacunes (1 point), presence of 1 or more cerebral microbleeds (1 point), 
moderate to severe BG-PVS (i.e. presence of >10 BG-PVS; 1 point) and WMH (periventricular 
WMH Fazekas grade 3 or deep WMH greater than Fazekas grade 2; 1 point) [3].  
 
 
PET acquisition and analysis 
All patients completed a [11C] PiB PET scan at either the Samsung Medical Center or the Asan 
Medical Center, using identical settings and a Discovery STe PET/CT scanner (GE Medical 
Systems, Milwaukee, WI, USA) in both cases. [11C] PiB-PET scanning was performed in 3-
dimensional scanning mode that examined 35 slices of 4.25-mm thickness spanning the entire 
brain. [11C] PiB was injected into an antecubital vein as a bolus with a mean dose of 420 MBq 
(range 259 to 550 MBq). A CT scan was performed for attenuation correction 60 minutes after 
injection. A 30-minute emission static PET scan was then initiated. The specific radioactivity of 
[11C] PiB at the time of administration was more than 1,500 Ci/mmol for patients and the 
radiochemical yield was more than 35%. The radiochemical purity of the tracer was more than 
95% for all PET studies. 
 
PiB PET images were co-registered to individual MRIs, which were normalized to a Montreal 
Neurological Institute (MNI)-152 template[30]. The quantitative regional values of PiB retention 
on the spatially normalized PiB images were obtained by an automated VOIs analysis using the 
automated anatomical labeling (AAL) atlas. Data processing was performed using SPM Version 
5 (SPM5) within Matlab 6.5 (MathWorks, Natick, MA). 
 
We selected 28 cortical VOIs from left and right hemispheres using the AAL atlas. The cerebral 
cortical VOIs that were chosen for this study consisted of the bilateral frontal (superior and middle 
frontal gyri, the medial portion of superior frontal gyrus, the opercular portion of inferior frontal 
gyrus, the triangular portion of inferior frontal gyrus, supplementary motor area, orbital portion of 
the superior, middle, and inferior orbital frontal gyri, rectus and olfactory cortex), posterior 
cingulate gyri, parietal (superior and inferior parietal, supramarginal and angular gyri, and 
precuneus), lateral temporal (superior, middle and inferior temporal gyri, and heschl gyri), and 
occipital (superior, middle, and inferior occipital gyri, cuneus, calcarine fissure, and lingual and 
fusiform gyri). Regional cerebral cortical uptake ratios were calculated by dividing each cortical 
VOI’s uptake ratio by the mean uptake of the cerebellar cortex (cerebellum crus1 and crus2), in 
order to obtain standardized uptake value ratios (SUVR). Global PiB uptake ratio was calculated 
from the volume-weighted average uptake ratio of bilateral 28 cerebral cortical VOIs. Patients 
were considered PiB-positive if their global PiB uptake ratio was greater than 1.5.  
 
 Image processing for cortical thickness measurement 
The CIVET anatomical pipeline was used to extract cortical thickness (http://mcin-
cnim.ca/neuroimagingtechnologies/civet/) [32]. In brief, using a linear transformation, native MRI 
images were registered to the MNI-152 template [30]. The N3 algorithm was used to correct the 
images for intensity-based non-uniformities [33] caused by the inhomogeneities in the magnetic 
field. Then, the registered and corrected images were classified into white matter, grey matter, 
cerebrospinal fluid and background using a 3D stereotaxic brain mask and the Intensity-
Normalized Stereotaxic Environment for Classification of Tissues (INSECT) algorithm [34]. The 
surfaces of the inner and outer cortex were automatically extracted using the Constrained 
Laplacian-based Automated Segmentation with Proximities (CLASP) algorithm [35]. 
 
Cortical thickness was defined as the Euclidean distance between the linked vertices of the inner 
and outer surfaces; there were 40,962 vertices in each hemisphere in native space [35]. The cortical 
thickness value was spatially normalized using surface-based two-dimensional registration with a 
sphere-to-sphere warping algorithm. Thus, the vertices of each subject were nonlinearly registered 
to a standard surface template to compare cortical thickness across subjects [36, 37]. Cortical 
thickness was subsequently smoothed using a surface-based diffusion kernel in order to increase 
the signal-to-noise ratio. We chose a 20-mm full-width at half-maximum kernel size to maximize 
statistical power while minimizing false positives [38]. Using these  methods, we obtained the 
mean cortical thickness values for each lobe. 
 
The presence of extensive WMH in the MRI scans made it difficult to completely delineate the 
inner cortical surface with the correct topology due to tissue classification errors. To overcome 
this technical limitation, we automatically defined the WMH region using a FLAIR image and 
substituted it for the intensity of peripheral, normal-appearing tissue on the high-resolution T1 
image after affine co-registration, as described in earlier studies [39]. 
 
Network analysis 
Network nodes were defined based on the automated anatomical labeling atlas [40], which 
parcellates the cerebral cortex into 78 areas (39 regions in each hemisphere). Individual T1-
weighted images were non-linearly registered to the MNI-152 template [30]. The AAL atlas was 
transformed from MNI space to T1 native space through inverse transformation with a nearest 
neighbor interpolation method. 
 
We corrected distortions in DTIs caused by eddy currents and simple head motions using the FSL 
(FMRIB’s Software Library) package diffusion toolbox in the FSL package 
(www.fmrib.ox.ac.uk/fsl/fdt). Diffusion tensor models were estimated, and the fractional 
anisotropy (FA) was calculated at each voxel. We reconstructed whole-brain white matter fiber 
tracts in native diffusion space for each subject using the fiber assignment of the continuous 
tracking algorithm [41] embedded in the Diffusion Toolkit (trackvis.org) [42]. We terminated 
tracking when the angle between two consecutive orientation vectors was greater than the given 
threshold of 45° or when both ends of the fibers extended outside of the white matter mask 
generated by the tissue segmentation process [43]. A fiber cutoff filter was applied such that fibers 
shorter than 20 mm and longer than 200 mm were eliminated. 
 
T1-weighted images were co-registered to the b0 images using the affine registration tool from the 
FSL package (www.fmrib.ox.ac.uk/fsl/ flirt). Reconstructed whole-brain fiber tracts were 
inversely transformed into the T1 space, and fiber tracts and AAL-based parcellated regions were 
located in the same space. Two nodes (regions) were considered to be structurally connected by 
an edge when at least the endpoints of three fiber tracts were located in these two regions. A 
threshold for the number of fiber tracts was selected to reduce the risk of false-positive connections 
due to noise or limitations in the deterministic tractography [43]. The FA value is considered an 
important index to evaluate fiber integrity [44], and in this study, the mean FA value along all 
fibers connecting pairs of regions was used to weight the edge. Finally, weighted structural 
networks represented by symmetric 78 * 78 matrices were constructed for each individual. 
 
Graph theoretical analyses were carried out on weighted connectivity networks using the Brain 
Connectivity Toolbox (www.brain-connectivity-toolbox.net)[46]. To measure network integration 
(the ability to rapidly combine specialized information from distributed nodes), we calculated the 
average shortest path length between all pairs of nodes and global efficiency in the network. We 
also calculated the weighted clustering coefficient, transitivity and modularity as measures of 
network segregation (the ability for specialized processing to occur within densely interconnected 
groups of nodes). Particularly for path analyses, we used nodal efficiency as a nodal topological 
characteristic of structural network, defined using the inverse of the weighted shortest path length 
between a given node and all other nodes in the network[46]. The definitions of these network 
measures and computation methods have been described previously[45-47]. Averaged values of 
the nodal efficiency in the frontal, temporal, and parietal regions predefined in the AAL atlas were 
used. Of 243 subjects, we excluded 18 patients for whom the quality of diffusion image (low 
signal-to-noise ratio) was not sufficient to reconstruct reliable fiber tracts. Thus network analysis 
was performed in 225 subjects (Figure 1).  
 
Statistical analysis  
For baseline characteristics, the mean and standard deviation were presented for continuous 
variables (age, years of education, cognitive and neuropsychological scores, global PiB-SUVR), 
and frequency and percentage of total population for categorical variables (sex, cardiovascular risk 
factors, APOE genotype, PiB positivity, components of SVD score). The median and interquartile 
range was presented for ordinal variables (SVD score).  Multiple linear regression analyses 
(adjusted for age, sex, and education) were used to explore the relationship between SVD score 
and neuropsychological test results, cortical thickness and structural network measures; linear 
regression (adjusted as above) was also performed for PiB positivity, to evaluate its relative 
contribution to cognitive domains significantly associated with SVD score. 
 
For cortical thickness analyses, we used a MATLAB-based toolbox (available free online at the 
University of Chicago website: 
http://galton.uchicago.edu/faculty/InMemoriam/worsley/research/surfstat/). In order to analyze 
the localized differences and the statistical map of cortical thickness on the surface model 
according to increasing SVD score (from 0 to 4), linear regression was performed vertex-by-vertex 
after controlling for age, sex, education, PiB positivity, and intracranial volume (ICV). The 
resulting statistical maps were thresholded using a RFT with a p-value of 0.05, after pooling the 
p-values from the regression analysis. 
 
To evaluate whether alteration of the WM network mediates the effects of SVD score on cortical 
thickness and cognition, path analyses were performed after controlling for age, sex, and 
education. Path analyses were performed for cognitive domains which showed significant 
associations with total SVD score in multiple linear regression analyses. In the structural equation 
modeling (SEM), we inserted all possible covariates including SVD score and PiB SUVR as 
exogenous variables and network measures, cortical atrophy and cognitive score as endogenous 
variables in the order according to the hypothesis. We selected nodes or cortical regions that were 
related to frontal-executive (bilateral frontal lobe) and visuospatial (bilateral parietal lobe) 
function. Path analysis using frontal score as the outcome was performed using mean frontal nodal 
efficiency and mean frontal thickness as mediators (path analysis A). Path analyses using 
visuospatial score as the outcomes were performed using mean parietal nodal efficiency/cortical 
thickness as mediators, respectively (path analysis B). SPSS Amos Version 18.0 software (SPSS, 
Chicago, IL, USA) was used for all path analyses.  
 
RESULTS 
From the original cohort (n=251), 243 patients were included in the cognitive and cortical atrophy 
analyses, and 225 in the network analyses; reasons for exclusion are provided in Figure 1.  Baseline 
characteristics for the included cohort are presented in Table 1.  
 
We first investigated the relationship between total SVD score with composite scores for five 
cognitive domains (Table 2). Total SVD score was significantly associated with deficits in frontal 
(β -4.31, SE 2.09, p = 0.040) and visuospatial (β -0.95, SE 0.44, p = 0.032) performance. When 
looking at associations with PiB positivity together, we found that this was significantly associated 
with deficits in memory (β -14.78, SE 2.69, p < 0.001) and language (β -3.46, SE 1.52, p = 0.024), 
with an associative trend between PiB positivity and visuospatial (β -2.28, SE 1.25, p = 0.070) 
performance.  
 
We then investigated the relationship between cortical thickness, total SVD score and PiB 
positivity (Table 3). Total SVD score was negatively associated with mean cortical thickness, 
globally and regionally. A statistical map of cortical thickness showed that increasing SVD score 
was associated with cortical thinning in widespread regions, in particular frontal (lateral, medial, 
inferior) and superior temporal regions (Figure 2). PiB positivity showed a trend for an overall 
negative association (β -0.049, SE 0.028, p = 0.082) and was regionally correlated with temporal 
cortical thickness (β -0.090, SE 0.033, p = 0.007), with a trend towards a negative association with 
occipital cortical thickness (β -0.049, SE 0.027, p = 0.067).  
 We next reviewed the associations between total SVD score and structural network measures 
(Table 4). The most striking finding was that SVD score was highly and significantly correlated 
with all structural network measures of network strength, while there were no significant 
associations between PiB positivity and any of the network measures evaluated. Increasing SVD 
score was associated with a change in network organization, with reduced network integration 
(increasing path length and lower global efficiency) and increased network segregation (clustering 
coefficient, transitivity, modularity) (Table 4). Total SVD score was negatively correlated with 
nodal efficiency across frontal (β -0.182, SE 0.028, p < 0.001), temporal (β -0.015, SE 0.002, p < 
0.001), and parietal (β -0.171, SE 0.030, p < 0.001) networks.  
 
We then performed path analyses for frontal and visuospatial scores which showed significant 
associations with total SVD score in multiple linear regression analyses. (Figure 3; Table 5). The 
path analysis evaluating frontal score demonstrated goodness to fit the data (χ2 = 5.83, degrees of 
freedom = 5, p = 0.323, comparative fit index = 0.998, root mean square error of approximation = 
0.027 (90% CI 0.000 to 0.100)). Increasing SVD score was associated with a decrease in mean 
frontal nodal efficiency, which itself was associated with a decrease in mean frontal thickness; 
these two parameters together contributed to impaired frontal-executive function. Decreased 
frontal nodal efficiency was also associated with reduced frontal score independently of frontal 
thickness. Increased global PiB SUVR was associated with lower frontal score, independently of 
frontal nodal efficiency or frontal thickness. The path analysis for visuospatial score showed 
goodness to fit the data (χ2 = 5.77, degrees of freedom = 3, p = 0.124, comparative fit index = 
0.991, root mean square error of approximation = 0.064 (90% CI 0.000 to 0.142)). Increasing SVD 
score was associated with reduced parietal nodal efficiency, which itself has its effect on 
visuospatial score via parietal thickness. Reductions in parietal nodal efficiency also had a negative 
direct effect on visuospatial score, independent of the effect mediated by parietal thickness. Global 
PiB SUVR had a direct effect on parietal thickness with no effect on parietal nodal efficiency.  
 
DISCUSSION   
In a memory clinic population, we report that higher total SVD burden, as measured by a composite 
SVD score is associated with: (1) reductions in frontal and visuospatial cognitive function; (2) 
reduced cortical thickness across a number of regions, in particular in frontal and superior temporal 
regions; (3) altered brain network organization, with reduced integration and increased 
segregation. The presence of Aβ, as measured by PiB positivity, was associated with impairments 
in memory and language scores, and reduced temporal cortical thickness, but did not have an 
impact upon any of the network measures considered. Additionally, in path analyses for both 
frontal and visuospatial scores, total SVD score had direct effects upon nodal efficiency, which in 
turn had negative effects on cortical thickness and cognitive performance.  
 
This is the first time that this total SVD score has been used in a memory clinic cohort. Our mean 
score is higher than those in previously published cohorts [3-6, 8, 11] (1.9, compared with 
calculated means between 0.6 and 1.7). This suggests that there is significant burden of SVD in 
this cohort, above that observed in ischemic stroke (including lacunar stroke and TIA), 
hypertensive and healthy elderly populations. Our results are in keeping with studies in other 
populations, which have shown an association between total SVD score and cognitive deficits in 
multiple domains including memory, executive functioning and information processing speed, as 
well as general or overall cognitive ability[4, 5] and longitudinal cognitive decline[6]. However, 
we have extended these observations by demonstrating that total SVD score is also related to 
cortical thickness and brain network measures, highlighting processes by which structural SVD 
damage may result in cognitive impairment. Our path analyses show that regional nodal efficiency 
has both a direct and an indirect (via regional cortical atrophy) effect upon cognitive performance 
in two different domains, suggesting that subcortical damage intrinsically disrupts network 
efficiency, leading to cortical atrophy and impairment of tasks requiring cortical integration (i.e. 
those that rely on “distributed systems” and may be particularly susceptible to 
“disconnection”[50]). Previous results from this cohort have shown an association between 
individual structural markers of SVD, specifically WMH and lacunes[45], and cerebral network 
disruption. However, our results are in contrast with previous work, which did not find any 
association between total SVD score and cerebral atrophy[3]. This might be because the previous 
study used a visual rating scale rather than a quantitative measure of cortical thickness.  
 
These results also add to our understanding of how different age-related pathologies may affect 
the brain. In contrast with the clear and direct impact of total SVD score on cerebral networks, we 
did not find any association of Aβ burden with structural network measures (again, a finding that 
has previously been described in this cohort[17]). This may reflect the relative impact that amyloid 
pathology and small vessel damage have on the white matter tracts that underlie brain network 
connections. The relatively meagre blood supply of these tracts means that they are particularly 
vulnerable to hypoxia and the effects of small vessel damage[51]. In contrast, Aβ appears to exert 
its effects either directly (frontal-executive function) or via cortical thickness (visuospatial score); 
this may reflect an effect on network “hubs” rather than connections, which are likely to be in the 
grey matter, and is in keeping with the predominantly cortical distribution of Aβ pathology[52].  
 
The strengths of this study are that this is a well characterized prospective patient cohort, with 
detailed phenotyping and standardized imaging for all participants. There are also some 
limitations. Firstly, these findings may only be applicable to a selected memory clinic population 
rather than the full spectrum of dementia syndromes that can be encountered in this setting; 
moreover, our diagnoses were made clinically without pathological verification, and the criteria 
for patient selection may have resulted in the exclusion of patients with a high burden of both SVD 
and Aβ pathology. Additionally, we chose to consider the cohort as a whole rather than by 
diagnosis (as we wished to focus on the impact of small vessel disease as a pathology), which may 
have made our data more heterogenous than if each category was considered individually.  
Secondly, patients underwent PiB PET at two centers; although the scanner settings and imaging 
preprocessing methods were identical, we cannot rule out an inter-scanner effect. Thirdly, there 
are limitations of single diffusion tensor-based deterministic tractography algorithms, because this 
method cannot detect fiber crossings. Future studies using advanced diffusion acquisition methods, 
where crossing fibers are included in the model, are warranted to construct enhanced anatomical 
networks. Finally, the total SVD score has some intrinsic limitations. The interaction between 
individual markers is likely to be more complex than simple summation of their effects, and the 
individual markers may have independent effects upon clinical outcomes (as seen with WMH and 
lacunes[17]), information which is lost once the score is generated.  
 In summary, total SVD burden has clinical relevance in a memory clinic population, and correlates 
with cognitive performance of frontal-executive and visuospatial tasks, cortical atrophy in multiple 
regions, as well as network strength, efficiency and organization. Further work is needed to 
confirm the potential of the total SVD score in other dementia syndromes. 
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TABLES 
Table 1: Baseline characteristics of participants (n=243) 
Demographics 
Mean age, years (SD) 72.2 (8.1) 
Sex, female, n (%) 143 (58.8) 
Years of Education, mean (SD) 10.0 (5.4) 
  
Cardiovascular risk factors 
Hypertension, n (%) 154 (63.4) 
Diabetes mellitus, n (%) 48 (19.8) 
Hyperlipidemia, n (%) 72 (29.6) 
Previous clinical history of stroke, n (%) 38 (15.6) 
  
APOE genotype† 
ε2 allele carrier, n (%) 24/238 (10.1) 
ε4 allele carrier, n (%) 87/238 (36.6) 
  
Cognitive scores 
MMSE, mean score, (SD) 22.9 (5.1) 
CDR_SB, mean score, (SD) 3.7 (3.2) 
  
Neuropsychological scores 
Attention, mean score, (SD) 8.3 (2.4) 
Language, mean score, (SD) 35.1 (11.5) 
Visuospatial, mean score, (SD) 24.7 (9.7) 
Memory, mean score, (SD) 61.3 (20.8) 
Frontal, mean score, (SD) 81.3 (45.0) 
  
PiB-PET measures 
Global PiB-SUVR, mean (SD) 1.7 (0.5) 
PiB positive, n (%) 130 (53.5) 
  
SVD score 
Total SVD score, median (IQR) 2 (0-3) 
Lacunes, presence, n (%) 140 (57.6) 
Cerebral microbleeds, presence, n (%) 103 (41.4) 
Moderate or severe WMH, presence, n (%) 147 (60.5) 
Moderate to severe BG-PVS, presence, n (%) 71 (29.2) 
 
 
†APOE genotyping was performed in 238 out of 243 participants. 
Abbreviations: APOE, Apolipoprotein E; CDR_SB, Clinical Dementia Rating sum or boxes; IQR, 
interquartile range; MMSE, Mini-mental status examination; PiB, Pittsburgh compound B; SD, 
standard deviation; SVD, small vessel disease.  
Table 2: Summary of multiple linear regression models investigating the relationship between 
neuropsychological composite scores and imaging parameters of interest (SVD score, PiB 
positivity) 
Neuropsychological Composite 
Score 
SVD score PiB positivity 
R2 
β (SE) p value β (SE) p value 
Attention -0.12 (0.10) 0.254 0.19 (0.30) 0.528 0.254 
Language -0.15 (0.54) 0.779 -3.46 (1.52) 0.024 0.151 
Visuospatial -0.95 (0.44) 0.032 -2.28 (1.25) 0.070 0.174 
Memory 1.54 (0.95) 0.106 
-14.78 
(2.69) 
<0.001 0.189 
Frontal -4.31 (2.09) 0.040 -8.64 (5.95) 0.147 0.145 
 
Age, sex, and education were entered as covariates for all models. 
Abbreviations: β, Unstandardized regression coefficient; COWAT, Controlled Oral Word 
Association Test; K-BNT, Korean version of the Boston Naming Test; RCFT, Rey-Osterrieth 
Complex Figure Test; PiB, Pittsburgh compound B; SE, standard error; SVD, small vessel disease; 
SVLT, Seoul Verbal Learning Test. 
  
Table 3: Summary of multiple linear regression models investigating the relationship between 
cortical thickness and imaging parameters of interest (SVD score, PiB positivity) 
 SVD score PiB positivity 
R2 
β (SE) p value β (SE) p value  
Global cortical thickness -0.033 (0.010) 0.001 -0.049 (0.028) 0.082 0.138 
Frontal cortical thickness -0.043 (0.011) <0.001 -0.017 (0.031) 0.567 0.148 
Temporal cortical 
thickness 
-0.039 (0.012) 0.001 -0.090 (0.033) 0.007 
0.183 
Parietal cortical thickness -0.020 (0.010) 0.052 -0.045 (0.029) 0.122 0.098 
Occipital cortical thickness -0.029 (0.009) 0.003 -0.049 (0.027) 0.067 0.099 
 
Age, sex, and education were entered as covariates for all models. 
Abbreviations: β, unstandardized regression coefficient; PiB, Pittsburgh compound B; SE, 
standard error; SVD, small vessel disease. 
  
Table 4: Summary of multiple linear regression models investigating the relationship between 
structural network measures and imaging parameters of interest (SVD score, PiB positivity) 
 
SVD score PiB positivity R2  
β (SE) p value β (SE) p value  
Shortest path length  0.017 (0.004) <0.001 0.000 (0.012) 0.974 0.143 
Global efficiency -0.007 (0.001) <0.001 -0.001 (0.004) 0.781 0.177 
Clustering coefficient 0.258 (0.037) <0.001 0.019 (0.106) 0.858 0.284 
Transivity 0.241 (0.033) <0.001 -0.001 (0.094) 0.990 0.298 
Modularity 0.013 (0.002) <0.001 0.000 (0.006) 0.960 0.270 
      
Mean frontal nodal 
efficiency 
-0.182 (0.028) <0.001 0.061 (0.079) 0.439 
0.317 
Mean temporal nodal 
efficiency 
-0.015 (0.002) <0.001 0.008 (0.006) 0.177 
0.274 
Mean parietal nodal 
efficiency 
-0.171 (0.030) <0.001 -0.035 (0.086) 0.683 
0.260 
 
Age, sex, and education were entered as covariates. Abbreviations: β, unstandardized regression 
coefficient; PiB, Pittsburgh compound B; SE, standard error; SVD, small vessel disease. 
 
Table 5:  Effects of SVD score and global PiB SUVR as predictors on frontal (path analysis A) 
and visuospatial function (path analysis B) through mediators (mean nodal efficiency and mean 
cortical thickness) 
Path analysis A  
Mean frontal nodal 
efficiency 
Mean frontal thickness Frontal score 
  β SE p β SE p β SE p 
SVD score -0.429 0.058 <0.001 -0.092 0.075 0.186 0.056 0.064 0.424 
Global PiB SUVR 0.018 0.061 0.776 -0.075 0.069 0.215 -0.148 0.055 0.015 
Mean frontal nodal 
efficiency 
- - - 0.519 0.055 <0.001 0.311 0.072 <0.001 
Mean frontal thickness - - - - - - 0.278 0.060 <0.001 
Path analysis B 
 
Mean parietal 
nodal efficiency 
Mean parietal 
thickness 
Visuospatial score 
 β SE p β SE p β SE p 
SVD score -0.391 0.065 <0.001 -0.090 0.076 0.241 -0.041 0.067 0.560 
Global PiB SUVR -0.052 0.067 0.417 -0.162 0.074 0.018 -0.102 0.066 0.112 
Mean parietal nodal 
efficiency 
- - - 0.263 0.064 <0.001 0.171 0.066 0.011 
Mean parietal thickness - - - - - - 0.342 0.060 <0.001 
 
Abbreviations: β, standardized regression coefficient; PiB, Pittsburgh compound B; SE, standard 
error; SVD, small vessel disease. 
 FIGURE LEGENDS 
Figure 1: Flowchart demonstrating inclusion and exclusion of participants included within the study. 
 
Abbreviations:  
DTI, diffusion tensor imaging; MR, magnetic resonance. 
 Figure 2: Statistical map of cortical thickness according to increasing SVD score (range between 0 
and 4).  
Thresholds were applied using random field theory with a p-value of 0.05. The linear regression model 
was adjusted for age, sex, education, intracerebral volume and PiB positivity. Increasing SVD score 
is associated with cortical thinning in widespread regions including the frontal (lateral, medial, 
inferior) and superior temporal lobes.  
 
Abbreviations: PiB, Pittsburgh compound B; RFT, random field theory; SVD, small vessel disease. 
 Figure 3:  Schematic representation of the path analyses for frontal-executive (A) and visuospatial (B) 
scores. 
Small vessel disease (SVD) score and Aβ burden were entered as predictors. Mean nodal efficiency 
and mean cortical thickness were entered as mediators. Age, sex, and education were entered as 
covariates. Numbers on the paths are standardized coefficients that were statistically significant. 
 
Abbreviations: PiB, Pittsburgh compound B; SUVR, standardized uptake value ratios; SVD, small 
vessel disease. 
 
  
